FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004362238> ?p ?o ?g. }

• W2004362238 endingPage "91" @default.
• W2004362238 startingPage "83" @default.
• W2004362238 abstract "A new liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, performed by electrospray ionization in positive mode using a triple quadrupole mass spectrometry, has been developed and validated for the simultaneous determination of bortezomib (BORT), dasatinib (DASA), imatinib (IMAT), nilotinib (NILO), erlotinib (ERLO), lapatinib (LAPA), sorafenib (SORA), sunitinib (SUNI) and vandetanib (VAND) in human plasma. Separation is achieved on an Hypersil Gold(®) PFP column using a gradient elution of 10mM ammonium formate containing 0.1% formic acid (A) and acetonitrile containing 0.1% formic acid (B) at a flow rate of 0.3 mL/min. After addition of the internal standard and protein precipitation, the supernatant is diluted 2-fold in a mixture A and B (50/50, v/v). Two selected reaction monitoring transitions are used for each analyte: one is used for quantitation, the second one is used for confirmation. The standard curves are ranged from 2 ng/mL to 250 ng/mL for BORT, DASA and SUNI and from 50 ng/mL to 3500 ng/mL for the others and were fitted to a 1/x weighted linear regression model. The lowest limits of quantification were 2 ng/mL for BORT, DASA and SUNI and 50 ng/mL for the other TKIs. The method also showed satisfactory results in terms of sensitivity, specificity, precision (intra- and inter-day RSD from 3.7% to 13.8%), accuracy (from 86.8% to 113.5%), recovery as well as stability of the analytes under various conditions. The method also may contribute to better understand the relationship between pharmacokinetics and pharmacodynamics of TKIs in hematological malignancies and solid tumors." @default.
• W2004362238 created "2016-06-24" @default.
• W2004362238 creator A5021818608 @default.
• W2004362238 creator A5027279017 @default.
• W2004362238 creator A5044845545 @default.
• W2004362238 creator A5023217276 @default.
• W2004362238 date "2013-05-01" @default.
• W2004362238 modified "2023-09-30" @default.
• W2004362238 title "Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS" @default.
• W2004362238 cites W1967595833 @default.
• W2004362238 cites W1974168030 @default.
• W2004362238 cites W1977961949 @default.
• W2004362238 cites W1978514731 @default.
• W2004362238 cites W1982729445 @default.
• W2004362238 cites W1985320798 @default.
• W2004362238 cites W1990095055 @default.
• W2004362238 cites W1991671417 @default.
• W2004362238 cites W1992244448 @default.
• W2004362238 cites W1999032995 @default.
• W2004362238 cites W1999966467 @default.
• W2004362238 cites W2005123994 @default.
• W2004362238 cites W2012230273 @default.
• W2004362238 cites W2014563113 @default.
• W2004362238 cites W2015015957 @default.
• W2004362238 cites W2016323110 @default.
• W2004362238 cites W2022263713 @default.
• W2004362238 cites W2028969293 @default.
• W2004362238 cites W2030353836 @default.
• W2004362238 cites W2037535290 @default.
• W2004362238 cites W2052684594 @default.
• W2004362238 cites W2067294132 @default.
• W2004362238 cites W2076479050 @default.
• W2004362238 cites W2087624447 @default.
• W2004362238 cites W2089617058 @default.
• W2004362238 cites W2090004346 @default.
• W2004362238 cites W2090699402 @default.
• W2004362238 cites W2099465692 @default.
• W2004362238 cites W2100608938 @default.
• W2004362238 cites W2103841828 @default.
• W2004362238 cites W2110756709 @default.
• W2004362238 cites W2113788015 @default.
• W2004362238 cites W2115007832 @default.
• W2004362238 cites W2119680582 @default.
• W2004362238 cites W2124214040 @default.
• W2004362238 cites W2128502566 @default.
• W2004362238 cites W2140765540 @default.
• W2004362238 cites W2150501295 @default.
• W2004362238 cites W2151263077 @default.
• W2004362238 cites W2151566058 @default.
• W2004362238 cites W2160007211 @default.
• W2004362238 cites W2161821474 @default.
• W2004362238 cites W2171188310 @default.
• W2004362238 cites W2312804644 @default.
• W2004362238 cites W2329648702 @default.
• W2004362238 doi "https://doi.org/10.1016/j.jchromb.2013.01.037" @default.
• W2004362238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23562906" @default.
• W2004362238 hasPublicationYear "2013" @default.
• W2004362238 type Work @default.
• W2004362238 sameAs 2004362238 @default.
• W2004362238 citedByCount "93" @default.
• W2004362238 countsByYear W20043622382014 @default.
• W2004362238 countsByYear W20043622382015 @default.
• W2004362238 countsByYear W20043622382016 @default.
• W2004362238 countsByYear W20043622382017 @default.
• W2004362238 countsByYear W20043622382018 @default.
• W2004362238 countsByYear W20043622382019 @default.
• W2004362238 countsByYear W20043622382020 @default.
• W2004362238 countsByYear W20043622382021 @default.
• W2004362238 countsByYear W20043622382022 @default.
• W2004362238 countsByYear W20043622382023 @default.
• W2004362238 crossrefType "journal-article" @default.
• W2004362238 hasAuthorship W2004362238A5021818608 @default.
• W2004362238 hasAuthorship W2004362238A5023217276 @default.
• W2004362238 hasAuthorship W2004362238A5027279017 @default.
• W2004362238 hasAuthorship W2004362238A5044845545 @default.
• W2004362238 hasConcept C121608353 @default.
• W2004362238 hasConcept C126322002 @default.
• W2004362238 hasConcept C162356407 @default.
• W2004362238 hasConcept C170493617 @default.
• W2004362238 hasConcept C185592680 @default.
• W2004362238 hasConcept C2777379063 @default.
• W2004362238 hasConcept C2777413986 @default.
• W2004362238 hasConcept C2778019345 @default.
• W2004362238 hasConcept C2778087573 @default.
• W2004362238 hasConcept C2778695046 @default.
• W2004362238 hasConcept C2779438470 @default.
• W2004362238 hasConcept C2779490328 @default.
• W2004362238 hasConcept C2779536868 @default.
• W2004362238 hasConcept C2780333294 @default.
• W2004362238 hasConcept C31827203 @default.
• W2004362238 hasConcept C42362537 @default.
• W2004362238 hasConcept C43617362 @default.
• W2004362238 hasConcept C502942594 @default.
• W2004362238 hasConcept C55493867 @default.
• W2004362238 hasConcept C62478195 @default.
• W2004362238 hasConcept C71043704 @default.
• W2004362238 hasConcept C71924100 @default.
• W2004362238 hasConcept C74774607 @default.

• next